Role of Matrix Metalloproteases in Degradation of ECM
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Myocarditis I: Introduction
Myocarditis III: Medical Management
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Updated: Jul 8, 2026

Detection of Functional Matrix Metalloproteinases by Zymography
Published on: November 8, 2010
H Senzaki1, S Masutani, J Kobayashi
1Departments of Pediatric Cardiology and Pediatrics, Saitama Heart Institute, Saitama Medical School Hospital, Saitama, Japan. hsenzaki@saitama-med.ac.jp
患有川崎病且矩阵金属蛋白酶 (MMP) 或MMP/MMP组织抑制剂 (TIMP) 比率升高的患者对冠状动脉病变的敏感性增加. 药物可能是预防这些病变的治疗目标.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: